Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Anticancer Research|April 12, 2012
Molecular characterization of human cutaneous melanoma-derived cell linesZighereda Ogbah, Joan Anton Puig-Butille, Federico Simonetta, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2020
Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct-acting anti-viralsLydia Sastre, Jordi To-Figueras, Sabela Lens, et al.
Annals of Neurology|January 30, 2015
The MC1R melanoma risk variant p.R160W is associated with Parkinson diseaseGemma Tell-Marti, Joan Anton Puig-Butille, Miriam Potrony, et al.
Pigment Cell & Melanoma Research|September 27, 2017
Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of neviMaría Gabriela Vallone, Gemma Tell-Marti, Miriam Potrony, et al.
JAMA Dermatology|December 10, 2015
Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative MutationsMiriam Potrony, Joan Anton Puig-Butille, Paula Aguilera, et al.
Clinical Chemistry and Laboratory Medicine|April 22, 2016
Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomasMiriam Potrony, Celia Badenas, Bénédicte Naerhuyzen, et al.
JAMA Dermatology|September 1, 2016
Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial MelanomasThaís Corsetti Grazziotin, Ivette Alarcon, Renan Rangel Bonamigo, et al.
European Journal of Human Genetics : EJHG|May 1, 2018
Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11qMiriam Potrony, Joan Anton Puig-Butille, James M Farnham, et al.
Pageof 7